#HIVantigens
Replication-competent vaccinia Tiantan-based #HIV candidate vaccine combined with a #DNAvaccine component exhibits promising safety & tolerability profiles while eliciting a robust #ImmuneResponse against #HIVantigens. #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...
Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost - Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy - Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost
doi.org
August 21, 2025 at 12:15 PM